[1]
Pallagi, E. and Csóka, I. 2021. Patient expectations and regulatory needs in the risk-based drug development of cystic fibrosis. Acta Pharmaceutica Hungarica. 91, 1 (Jun. 2021), 3-10. DOI:https://doi.org/10.33892/aph.2021.91.3-10.